Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer
- PMID: 31011609
- PMCID: PMC6460223
- DOI: 10.1016/j.gore.2019.03.016
Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer
Abstract
The purpose of this study was to identify the prevalence of substance use disorder and its association with adherence to treatment and survival in locally advanced cervical cancer patients treated with primary radiation therapy. This is a retrospective case series of locally advanced cervical cancer patients with substance use disorder in a single academic institution treated with radiation therapy between 2005 and 2016. Substance use disorder was identified through chart review. Those with substance use disorder were compared to those without in regards to demographics, Charlson comorbidity index, treatment details and outcomes. Of the 129 patients with locally advanced cervical cancer, 16 (12.4%) were identified as having substance use disorder. Patients with substance use disorder were younger (42.1 years vs 51.5 years, p = .013) and more likely to be smokers (81.3% vs 42.5%, p = .004). The majority of patients with substance use disorder received concurrent chemotherapy (93.8%) and brachytherapy in addition to external beam radiation therapy (81.3%). There was no significant difference in days to completion of radiation therapy between patients with and without substance use disorder. Radiation dose received, toxicities and survival were similar between groups. Among cervical cancer patients receiving treatment with radiation therapy, substance use disorder was not associated with poorer adherence, longer radiation treatment times or a difference in total dose of radiation received. Our experience demonstrates that patients with substance use disorder are able to adhere to complex, multimodal treatment plans resulting in similar cancer specific outcomes compared to patients without substance use disorder.
Keywords: Cervical cancer; Substance use disorder; Treatment adherence.
Figures
Similar articles
-
Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.Am J Clin Oncol. 2018 May;41(5):447-451. doi: 10.1097/COC.0000000000000300. Am J Clin Oncol. 2018. PMID: 27258678
-
Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?BMC Cancer. 2019 Apr 25;19(1):385. doi: 10.1186/s12885-019-5594-4. BMC Cancer. 2019. PMID: 31023261 Free PMC article.
-
Radiation therapy with concurrent chemotherapy for locally advanced cervical carcinoma: outcome analysis with emphasis on the impact of treatment duration on outcome.Obstet Gynecol Int. 2014;2014:214351. doi: 10.1155/2014/214351. Epub 2014 Nov 5. Obstet Gynecol Int. 2014. PMID: 25431594 Free PMC article.
-
Why brachytherapy boost is the treatment of choice for most women with locally advanced cervical carcinoma?Brachytherapy. 2016 Mar-Apr;15(2):191-9. doi: 10.1016/j.brachy.2015.12.003. Epub 2016 Feb 1. Brachytherapy. 2016. PMID: 26810408 Review.
-
American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.Brachytherapy. 2017 Jan-Feb;16(1):22-43. doi: 10.1016/j.brachy.2016.03.008. Brachytherapy. 2017. PMID: 28109631 Free PMC article. Review.
Cited by
-
An Interdisciplinary Approach to Metastatic Pancreatic Cancer and Comorbid Opioid Use Disorder Treatment Within a VA Health Care System.Fed Pract. 2021 Aug;38(Suppl 3):S66-S71. doi: 10.12788/fp.0160. Fed Pract. 2021. PMID: 34733097 Free PMC article.
-
Facilitating gynecological examination and long acting reversible contraception for women with substance use disorder: a prospective cohort study.BMC Womens Health. 2025 May 24;25(1):252. doi: 10.1186/s12905-025-03794-0. BMC Womens Health. 2025. PMID: 40413445 Free PMC article.
References
-
- Childers J.W., King L.A., Arnold R.M. Chronic pain and risk factors for opioid misuse in a palliative care clinic. Am. J. Hosp. Palliat. Care. 2015;32:654–659. - PubMed
Publication types
LinkOut - more resources
Full Text Sources